nomifensine has been researched along with Sexual Dysfunction, Physiological in 1 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
Sexual Dysfunction, Physiological: Physiological disturbances in normal sexual performance in either the male or the female.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burrows, GD | 1 |
| Norman, TR | 1 |
| Dennerstein, L | 1 |
| Davies, BM | 1 |
1 review available for nomifensine and Sexual Dysfunction, Physiological
| Article | Year |
|---|---|
Antidepressant therapy: benefits and risks in perspective.
Topics: Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Depressive Disorder; Dibenzazepines | 1985 |